Expanding Access to mTBI Treatment for Veterans and Service Members With Co-occurring Substance Use

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Shepherd Center, Atlanta GA
Study ID
NCT06620900
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Brain Injury
  • Concussion, Mild Traumatic Brain Injury
  • Substance Use
  • Substance Use Disorder (SUD)
  • Traumatic Brain Injury

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Integrated Model of Care — OTHER
    The Integrated Model of Care was developed and piloted by the study team provide support for individuals seeking care in an interdisciplinary intensive outpatient program for mild traumatic brain injury to receive support for co-occurring substance use-related needs.

Study Details

The purpose of this research is to determine whether military veterans and service members with mild traumatic brain injury with and without co-occurring substance use can complete and benefit from integrated interdisciplinary care individualized to their symptoms, goals, and needs. Participants will complete surveys about substance use and other symptoms at the beginning and end of treatment in an intensive outpatient program and 6 months after discharge.

Key Dates

Start date
Feb 28, 2025
Status verified
Sep 2024
Primary completion
Aug 31, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
360 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Integrated Model of Care
    Participants will engage in interdisciplinary intensive outpatient program (IOP) treatment for mild traumatic brain injury with individualized support for substance use (SU) following which they will receive support for SU in the transition support program.

Primary Outcome Measure

Neurobehavioral Symptom Inventory (NSI) [ Time Frame: Study enrollment, immediately after the intervention, and at 6 months follow-up ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Shepherd CenterAtlantaGeorgia30309
Katherine L McCauley, PhD
404-603-4980
Russell K Gore, MD (PRINCIPAL_INVESTIGATOR)
Katherine L McCauley, PhD (SUB_INVESTIGATOR)
Tracey D Wallace, MS (SUB_INVESTIGATOR)

Find similar trials in Atlanta, GA

Related Studies